On January 24, 2024, Cytokinetics (NASDAQ: CYTK) received a revised rating from UBS analyst Ashwani Verma. Verma downgraded the stock ...
On August 20, 2023, it was reported that Russell Investments Group Ltd. has reduced its holdings in Cytokinetics, Incorporated (NASDAQ:CYTK) ...
In a recent disclosure with the Securities and Exchange Commission, Barclays PLC revealed that it has trimmed its holdings in ...
On June 26, 2023, the Securities & Exchange Commission disclosed that Stonnington Group LLC had acquired a new position in ...
